<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>3248</number>
    <updateDate>2023-01-11T13:43:52Z</updateDate>
    <updateDateIncludingText>2023-01-11T13:43:52Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <type>S</type>
    <introducedDate>2020-02-03</introducedDate>
    <congress>116</congress>
    <committees>
      <item>
        <systemCode>sscm00</systemCode>
        <name>Commerce, Science, and Transportation Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Reported by</name>
            <date>2020-11-17T21:44:32Z</date>
          </item>
          <item>
            <name>Markup by</name>
            <date>2020-03-11T14:00:02Z</date>
          </item>
          <item>
            <name>Referred to</name>
            <date>2020-02-03T20:35:45Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <committeeReports>
      <committeeReport>
        <citation>S. Rept. 116-301</citation>
      </committeeReport>
    </committeeReports>
    <relatedBills>
      <item>
        <title>United States Anti-Doping Agency Reauthorization Act of 2020</title>
        <congress>116</congress>
        <number>5373</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2020-09-30</actionDate>
          <text>Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
          <item>
            <type>Related bill</type>
            <identifiedBy>House</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2020-12-18</actionDate>
        <actionTime>14:52:46</actionTime>
        <text>Held at the desk.</text>
        <type>Floor</type>
        <actionCode>H15000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2020-12-18</actionDate>
        <actionTime>14:14:18</actionTime>
        <text>Received in the House.</text>
        <type>Floor</type>
        <actionCode>H14000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2020-12-18</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Message on Senate action sent to the House.</text>
        <type>Floor</type>
      </item>
      <item>
        <actionDate>2020-12-17</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S7642)</text>
        <type>Floor</type>
      </item>
      <item>
        <actionDate>2020-12-17</actionDate>
        <text>Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.</text>
        <type>Floor</type>
        <actionCode>17000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2020-12-17</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>The committee amendments withdrawn by Unanimous Consent. (CR S7641)</text>
        <type>Floor</type>
      </item>
      <item>
        <actionDate>2020-12-17</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Measure laid before Senate by unanimous consent. (consideration: CR S7641-7642)</text>
        <type>Floor</type>
      </item>
      <item>
        <actionDate>2020-11-17</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 594.</text>
        <type>Calendars</type>
      </item>
      <item>
        <actionDate>2020-11-17</actionDate>
        <committees>
          <item>
            <systemCode>sscm00</systemCode>
            <name>Commerce, Science, and Transportation Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Committee on Commerce, Science, and Transportation. Reported by Senator Wicker with amendments. With written report No. 116-301.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2020-11-17</actionDate>
        <text>Committee on Commerce, Science, and Transportation. Reported by Senator Wicker with amendments. With written report No. 116-301.</text>
        <type>Committee</type>
        <actionCode>14000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>sscm00</systemCode>
            <name>Commerce, Science, and Transportation Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2020-03-11</actionDate>
        <committees>
          <item>
            <systemCode>sscm00</systemCode>
            <name>Commerce, Science, and Transportation Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment favorably.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2020-02-03</actionDate>
        <committees>
          <item>
            <systemCode>sscm00</systemCode>
            <name>Commerce, Science, and Transportation Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Commerce, Science, and Transportation.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2020-02-03</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>M000934</bioguideId>
        <fullName>Sen. Moran, Jerry [R-KS]</fullName>
        <firstName>Jerry</firstName>
        <lastName>Moran</lastName>
        <party>R</party>
        <state>KS</state>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>B001277</bioguideId>
        <fullName>Sen. Blumenthal, Richard [D-CT]</fullName>
        <firstName>Richard</firstName>
        <lastName>Blumenthal</lastName>
        <party>D</party>
        <state>CT</state>
        <sponsorshipDate>2020-02-03</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <cboCostEstimates>
      <item>
        <pubDate>2020-09-28T20:04:00Z</pubDate>
        <title>S. 3248, United States Anti-Doping Agency Reauthorization Act of 2020</title>
        <url>https://www.cbo.gov/publication/56640</url>
        <description>As ordered reported by the Senate Committee on Commerce, Science, and Transportation on March 11, 2020</description>
      </item>
    </cboCostEstimates>
    <policyArea>
      <name>Sports and Recreation</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Alternative dispute resolution, mediation, arbitration</name>
        </item>
        <item>
          <name>Athletes</name>
        </item>
        <item>
          <name>Child health</name>
        </item>
        <item>
          <name>Congressional oversight</name>
        </item>
        <item>
          <name>Criminal investigation, prosecution, interrogation</name>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
        </item>
        <item>
          <name>Drug, alcohol, tobacco use</name>
        </item>
        <item>
          <name>Due process and equal protection</name>
        </item>
        <item>
          <name>International law and treaties</name>
        </item>
        <item>
          <name>International organizations and cooperation</name>
        </item>
        <item>
          <name>Mammals</name>
        </item>
        <item>
          <name>Medical tests and diagnostic methods</name>
        </item>
        <item>
          <name>Olympic games</name>
        </item>
        <item>
          <name>Veterinary medicine and animal diseases</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Sports and Recreation</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2020-02-03</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2020-05-28T18:29:23Z</updateDate>
        <text><![CDATA[ <p><strong>United States Anti-Doping Agency Reauthorization Act of 2020</strong></p> <p>This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2029.</p> <p>The bill also directs (1) USADA to promote a positive youth sport experience by using a portion of its funding to provide educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports; and (2) the Department of Justice, the Department of Homeland Security, and the Food and Drug Administration&nbsp;to provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.</p>]]></text>
      </summary>
      <summary>
        <versionCode>25</versionCode>
        <actionDate>2020-11-17</actionDate>
        <actionDesc>Reported to Senate</actionDesc>
        <updateDate>2020-12-23T19:18:18Z</updateDate>
        <text><![CDATA[ <p><strong>United States Anti-Doping Agency Reauthorization Act of 2020</strong></p> <p>This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2029.</p> <p>The bill also directs (1) USADA to promote a positive youth sport experience by providing educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports; and (2) the Department of Justice, the Department of Homeland Security, and the Food and Drug Administration&nbsp;to provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.</p> <p>USADA must submit to Congress a report that (1) assesses its capacity to implement an equine anti-doping and medication control program; and (2) includes recommendations concerning best practices for the successful implementation of such a program in the United States and recommendations developed in consultation with the National Veterinary Services Laboratories regarding the appropriate technical standards and best practices.]]></text>
      </summary>
      <summary>
        <versionCode>55</versionCode>
        <actionDate>2020-12-17</actionDate>
        <actionDesc>Passed Senate</actionDesc>
        <updateDate>2021-03-16T17:43:30Z</updateDate>
        <text><![CDATA[ <p><strong>United States Anti-Doping Agency Reauthorization Act of 2020</strong></p> <p>This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2029.</p> <p>USADA shall</p> <ul> <li>serve as the independent anti-doping organization for the amateur athletic competitions recognized by the U.S. Olympic and Paralympic Committee,</li> <li>be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within U.S. jurisdiction, and</li> <li>be recognized worldwide as the independent national anti-doping organization for the United States.</li> </ul> <p>Any administrative action taken by USADA to enforce a USADA policy, procedure, or requirement against a person with respect to a violation of federal law shall be carried out in a manner that provides due process protection to the person.</p> <p>The bill also directs (1) USADA to promote a positive youth sport experience by providing educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports; and (2) the Department of Justice, the Department of Homeland Security, and the Food and Drug Administration&nbsp;to provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.</p>]]></text>
      </summary>
    </summaries>
    <title>United States Anti-Doping Agency Reauthorization Act of 2020</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>United States Anti-Doping Agency Reauthorization Act of 2020</title>
      </item>
      <item>
        <titleType>Short Title(s) as Reported to Senate</titleType>
        <title>United States Anti-Doping Agency Reauthorization Act of 2020</title>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
        <billTextVersionName>Reported to Senate</billTextVersionName>
        <billTextVersionCode>RS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Passed Senate</titleType>
        <title>United States Anti-Doping Agency Reauthorization Act of 2020</title>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
        <billTextVersionName>Engrossed in Senate</billTextVersionName>
        <billTextVersionCode>ES</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>United States Anti-Doping Agency Reauthorization Act of 2020</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Titles as Passed Senate</titleType>
        <title>United States Anti-Doping Agency Reauthorization Act of 2020</title>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to reauthorize the United States Anti-Doping Agency, and for other purposes.</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
    </titles>
    <amendments>
      <amendment>
        <number>2715</number>
        <congress>116</congress>
        <type>SAMDT</type>
        <purpose>In the nature of a substitute.</purpose>
        <updateDate>2022-02-08T23:05:37Z</updateDate>
        <latestAction>
          <actionDate>2020-12-17</actionDate>
          <text>Amendment SA 2715 agreed to in Senate by Unanimous Consent.</text>
          <links>
            <link>
              <name>SA 2715</name>
              <url>https://www.congress.gov/amendment/116th-congress/senate-amendment/2715</url>
            </link>
          </links>
        </latestAction>
        <sponsors>
          <item>
            <bioguideId>M000934</bioguideId>
            <fullName>Sen. Moran, Jerry [R-KS]</fullName>
            <firstName>Jerry</firstName>
            <lastName>Moran</lastName>
            <party>R</party>
            <state>KS</state>
          </item>
        </sponsors>
        <proposedDate>2020-12-17T05:00:00Z</proposedDate>
        <submittedDate>2020-12-17T05:00:00Z</submittedDate>
        <chamber>Senate</chamber>
        <amendedBill>
          <congress>116</congress>
          <type>S</type>
          <originChamber>Senate</originChamber>
          <originChamberCode>S</originChamberCode>
          <number>3248</number>
          <title>United States Anti-Doping Agency Reauthorization Act of 2020</title>
          <updateDateIncludingText>2023-01-11T13:43:52Z</updateDateIncludingText>
        </amendedBill>
        <actions>
          <count>6</count>
          <actions>
            <item>
              <actionDate>2020-12-17</actionDate>
              <sourceSystem>
                <code>0</code>
                <name>Senate</name>
              </sourceSystem>
              <text>Amendment SA 2715 agreed to in Senate by Unanimous Consent.</text>
              <type>Floor</type>
            </item>
            <item>
              <actionDate>2020-12-17</actionDate>
              <sourceSystem>
                <code>0</code>
                <name>Senate</name>
              </sourceSystem>
              <text>Amendment SA 2715 proposed by Senator Braun for Senator Moran. (consideration: CR S7641-7642; text: CR S7642) In the nature of a substitute.</text>
              <type>Floor</type>
            </item>
            <item>
              <actionDate>2020-12-17</actionDate>
              <text>Senate amendment submitted</text>
              <type>Floor</type>
              <actionCode>91000</actionCode>
              <sourceSystem>
                <code>9</code>
                <name>Library of Congress</name>
              </sourceSystem>
            </item>
            <item>
              <actionDate>2020-12-17</actionDate>
              <text>Senate amendment proposed (on the floor): Amendment SA 2715 proposed by Senator Braun for Senator Moran.</text>
              <type>Floor</type>
              <actionCode>93000</actionCode>
              <sourceSystem>
                <code>9</code>
                <name>Library of Congress</name>
              </sourceSystem>
            </item>
            <item>
              <actionDate>2020-12-17</actionDate>
              <text>Senate amendment agreed to: Amendment SA 2715 agreed to in Senate by Unanimous Consent.</text>
              <type>Floor</type>
              <actionCode>94000</actionCode>
              <sourceSystem>
                <code>9</code>
                <name>Library of Congress</name>
              </sourceSystem>
            </item>
          </actions>
        </actions>
      </amendment>
    </amendments>
    <textVersions>
      <item>
        <type>Engrossed in Senate</type>
        <date>2020-12-17T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116s3248es/xml/BILLS-116s3248es.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Reported to Senate</type>
        <date>2020-11-17T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116s3248rs/xml/BILLS-116s3248rs.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Introduced in Senate</type>
        <date>2020-02-03T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116s3248is/xml/BILLS-116s3248is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2020-12-18</actionDate>
      <text>Held at the desk.</text>
      <actionTime>14:52:46</actionTime>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
